Can chemo before surgery beat bladder cancer? new study digs into the data.
NCT ID NCT06727214
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records of 87 adults with muscle-invasive bladder cancer who received platinum-based chemotherapy before surgery. Researchers want to see what factors influence how well the chemo works and whether it helps patients live longer without cancer. The goal is to better understand who benefits most from this approach.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- platinum-based chemotherapy
- What this could lead to
- If successful, this study could help doctors better predict which patients benefit most from chemotherapy before bladder cancer surgery.
- What could go wrong
- This is a small, retrospective study that looks back at medical records, not a controlled trial. Results may not apply to all patients and cannot prove cause and effect.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Pre-Surgery chemotherapy outsmart aggressive bladder cancer?
- Bladder cancer: a new combo aims to avoid radical surgery
- Can a special PET scan see bladder cancer more clearly?
- Bladder cancer surgery: what happens after the bladder is removed?
- Bladder cancer breakthrough? new combo aims to save the bladder
- Lab-Grown tumor clusters guide tailored bladder cancer therapy